This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Characteristics of exceptional responders to lenalidomide-based therapy in multiple myeloma
Blood Cancer Journal Open Access 23 October 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheridan, C. Cancer centers zero in on exceptional responders. Nat Biotechnol 32, 703–704 (2014). https://doi.org/10.1038/nbt0814-703
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0814-703
This article is cited by
-
Informing materials: drugs as tools for exploring cancer mechanisms and pathways
History and Philosophy of the Life Sciences (2017)
-
Characteristics of exceptional responders to lenalidomide-based therapy in multiple myeloma
Blood Cancer Journal (2015)